Latest news
Loading news…
ACELYRIN
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Los Angeles, California, United States Founded 2020 101-250 employees For Profit
ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.
ACELYRIN was acquired by Alumis in 2025.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
76
Ticker
SLRN
NASDAQ
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- SLRN
- Exchange
- NASDAQ
- IPO date
- May 5, 2023
- Raised at IPO
- $540M
- Valuation at IPO
- $2B
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 17
- IT spend
- $8M
Company Info
- Founded
- 2020
- Employees
- 101-250
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 153
- HQ
- Los Angeles, California, United States
- Region
- Greater Los Angeles Area, West Coast, Western US
- Exit date
- May 5, 2023
Signals & Scores
- Heat score
- Medium
- Trend (7d)
- -0.3
- Trend (30d)
- -0.7
- Trend (90d)
- 4.1
- Last leadership hire
- Feb 15, 2024
- Last layoff mention
- Aug 14, 2024
Acquisitions by ACELYRIN
Loading columns…
0 of 0Show
Page 1 / 1
Key People at ACELYRIN
Chief Technical Operations Officer
Chief Medical Officer
Senior Vice President, Investor Relations and Corporate Communications
Chief Legal Officer
76
professional contacts at ACELYRIN
Contact execs at ACELYRIN →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to ACELYRIN
Loading news…
FAQs about ACELYRIN
People who checked this page also checked these
Sectors ACELYRIN invests & acquires in
Browse the full Acquirezy directory.